UBS Maintains a 'Neutral' on Amphenol (APH); Raising Estimates and Price Target
Tweet
Share
E-mailGet Alerts APH Hot Sheet
Price: $153.11 -1.88%
Rating Summary:
16 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
16 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
UBS maintains a 'Neutral' on Amphenol (NYSE: APH) price target raised from $55 to $60.
Analyst, Amitabh Passi, said, "1Q (revs up 3.5% q/q, 4.4% y/y, or 1.3% q/q and flat y/y organically), we raise our CY12 Rev/EPS estimates slightly to $4.16b/$3.35 from $4.11b/$3.29. Adjusting for acqs, we foresee CY12 revenues up ~2% org. y/y, vs. flat org. growth y/y in 1Q12. We forecast 2h/1h rev growth of 5%, in-line with APH guidance, and compared to double digit growth in 5 of the past 8 yrs. While there could be upside to FY estimates, we believe current guidance is prudent this early in the year."
For an analyst ratings summary and ratings history on Amphenol click here. For more ratings news on Amphenol click here.
Shares of Amphenol closed at $58.09 yesterday.
Analyst, Amitabh Passi, said, "1Q (revs up 3.5% q/q, 4.4% y/y, or 1.3% q/q and flat y/y organically), we raise our CY12 Rev/EPS estimates slightly to $4.16b/$3.35 from $4.11b/$3.29. Adjusting for acqs, we foresee CY12 revenues up ~2% org. y/y, vs. flat org. growth y/y in 1Q12. We forecast 2h/1h rev growth of 5%, in-line with APH guidance, and compared to double digit growth in 5 of the past 8 yrs. While there could be upside to FY estimates, we believe current guidance is prudent this early in the year."
For an analyst ratings summary and ratings history on Amphenol click here. For more ratings news on Amphenol click here.
Shares of Amphenol closed at $58.09 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
- Seaport Global Securities Upgrades Analog Devices (ADI) to Buy, 'appears to be entering the sweet part of the cycle'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
